Cost–utility analysis of minimally invasive surgery for lung cancer: A randomized controlled trial
European Journal of Cardio-Thoracic Surgery Mar 09, 2019
Bendixen M, et al. - In order to investigate the cost-effectiveness of video-assisted thoracic surgery (VATS), researchers designed this study as a cost-utility analysis of the first 12 months following surgery. They performed this study together with a clinical randomized controlled trial of VATS vs thoracotomy for lobectomy of stage 1 lung cancer during a 6-year period (2008–2014). They randomized 103 VATS patients and 103 thoracotomy patients. Mean costs per patient operated by VATS were 103,108 Danish Kroner (Dkr) (€13 818) and by thoracotomy were 134,945 Dkr (€18 085). This suggests the costs for VATS 31,837 Dkr (€4267) lower than thoracotomy. Findings thus support that in stage 1 lung cancer, VATS is a cost-effective alternative to thoracotomy following lobectomy. Significantly better economical outcomes as measured by quality-adjusted life years and lower overall costs for VATS were evident.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries